AR-209

N/A

Report date: 2024/12/03 16:45:12
NME

Base Information

Drug NameAR-209
Drug Alias NamePseudomonas fusion toxinReT-9Anti-erbB-2OLX-209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAntigenics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntigenics Llc
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A